BMY vs ABBV
BMY and ABBV side by side — valuation & fundamentals (public data).
Key statistics
| Metric | BMYBRISTOL-MYERS SQUIBB COMPANY | ABBVAbbVie Inc. |
|---|---|---|
| Market cap | $129.94B | $463.96B |
| P/E (TTM) | 14.0 | 74.2 |
| P/B | 5.82 | — |
| P/S | 2.7x | 7.6x |
| Dividend yield | 3.88% | 2.51% |
| Revenue | $49.19B(TTM) | $61.16B(TTM) |
| Revenue growth (YoY) | -0.2% | 8.6% |
| Net income | $9.28B(TTM) | $6.31B(TTM) |
| Earnings growth (YoY) | 178.8% | -1.2% |
| EPS, diluted | $4.54(TTM) | $3.54(TTM) |
| EBIT margin | 21.8% | 24.6% |
| ROE | 31.6% | — |
| ROIC | 14.0% | 18.6% |
| Piotroski F | 7/9 | — |
| 1y total return | +42.6% | +24.5% |
Figures from SEC filings · for reference only · not investment advice
$10,000 투자 성장: BMY vs ABBV
| 지표 | BMY | ABBV |
|---|---|---|
| 최종 가치 | $12.8K | $64.4K |
| 총수익률 | +27.8% | +543.9% |
| CAGR | +2.4% | +19.7% |
| 변동성 | 25.3% | 25.9% |
| 샤프 | 0.06 | 0.67 |
| 소르티노 | 0.08 | 0.93 |
| 최대 낙폭 | -47.7% | -45.1% |
공통 거래일 2600일 기준, 2016-05-13 → 2026-09-16 · 무위험수익률 4.11% (현재 단기 국채 금리, 고정 적용)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)